Gyre Therapeutics Inc (GYRE)

Investing Cash Flow

$9.76M

Quarterly · Period ending: · USD

GYRE logo

GYRE Investing Cash Flow

Latest reported$9.76M
GYRE Quarterly Cash from Investing (-$118.52K → $9.76M)
High-resolution chart · PNG

GYRE investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
9,757,000
-3,055,000
1,848,000
-1,247,000
-3,042,000
1,967,000
-2,004,000
-2,387,000
-8,273,000
-7,220,000
1,339,000
-5,400,000
-8,051,000
-7,648,000
-69,189,000
0
52,871,000
-3,122,355
2,866,000
7,038,000
10,704,000
27,581,000
27,551,000
-21,267,000
-24,042,000
27,421,000
440,000
14,628,000
3,661,000
8,663,000
4,155,000
-3,638,000
-72,641,000
803,000
-1,526,000
-16,486,000
-19,000
6,779,000
5,841,000
2,383,000
-5,760,000
-3,772,000
10,975,000
-5,269,000
10,614,000
21,037,000
14,253,000
10,184,000
7,484,000
1,935,000
3,936,000
8,549,000
3,777,000
-2,853,000
15,834,000
16,736,000
460,000
6,792,000
-2,191,000
-18,999,000
-30,938,000
-5,539,000
-6,236,000
-20,041,000
-19,353,000
-17,169,000
-48,000
-30,000
9,971,000
-93,000
-5,071,220
5,177,266
7,669,585
-13,294,631
1,568,789
-18,824,351
-8,421,223
-609,377
-322,375
-145,346
-12,608,421
-191,276
-13,444
-3,991
-114,291
-118,521
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.